Article
Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain.
Scientific reports - 28 Apr 2021
Smaoui Mohamed Raef, Yahyaoui Hamdi
Abstract excerpt
The interaction between the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein and the ACE2 enzyme is believed to be the entry point of the virus into various cells in the body, including the lungs, heart, liver, and kidneys. The current focus of several therapeutic design efforts explores attempts at affecting the binding potential between the two proteins to limit the activity of the virus and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
